UNSPSC 85763027: Removal of autologous tissue substitute from upper back, percutaneous approach

This classification denotes the group of activities that yields a surgical intervention or procedure to removal of autologous tissue substitute from upper back, percutaneous approach. This surgical intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 0WPK37Z

UNSPSC 85763027 (Removal of autologous tissue substitute from upper back, percutaneous approach), a Commodity code, does not align with the recent state and local procurement activity tagged under it. The code nominally describes a specific surgical procedure, but the recent opportunities posted under this code reflect healthcare administrative services, benefits management, and medical staffing procurement — not surgical procedures or tissue removal services. The City of Phoenix Retirement Office is soliciting independent medical evaluation services for disability pension determinations; the City of Long Beach is requesting surgical and medical procedure carve-out benefit management through Centers of Excellence; the Washington State Department of Transportation is procuring occupational medical surveillance services; Harris County Juvenile Probation Department is seeking emergency and specialty medical services for detained youth; Collier County is requesting pharmacy benefit management services; and Santa Clara Health System is establishing a qualified vendor pool for temporary health professional staffing across ancillary clinical categories. None of these solicitations involve autologous tissue substitutes or percutaneous surgical removal.

The recent opportunities span state transportation agencies, county purchasing offices, city benefits divisions, and health system human resources functions, distributed across Washington, Arizona, California, Texas, and Florida. Because the code's nominal scope diverges substantially from the actual work being procured under it in state and local markets, this code shows little decision-relevant recent activity for firms pursuing business in surgical procedures, implantable devices, or related clinical product supply. Pursuit of opportunities under this code requires verification that issuing bodies are applying the code correctly to the work they are actually buying.